Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.21.00917

PubMed Identifier: 34464155

Publication URI: http://europepmc.org/abstract/MED/34464155

Type: Journal Article/Review

Volume: 39

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 30

ISSN: 0732-183X